Cornerstone Pharmaceuticals Inc.
CRANBURY, New Jersey, August 17, 2010 - Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today
announced that Dorit Arad, Ph.D., has been appointed director of research and
development for the company's operations in Israel.
